Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-23
DOI
10.1038/srep41138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization
- (2015) C Hwangbo et al. ONCOGENE
- DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance
- (2015) Roland M. Huber et al. Oncotarget
- Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors
- (2015) D Klein et al. Oncogenesis
- MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
- (2014) Christopher J. Cheng et al. NATURE
- Loss of Stromal Caveolin-1 Expression: A Novel Tumor Microenvironment Biomarker That Can Predict Poor Clinical Outcomes for Pancreatic Cancer
- (2014) Tao Shan et al. PLoS One
- CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition
- (2014) Wu Liang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models
- (2013) Salahaldin A. Tahir et al. CANCER BIOLOGY & THERAPY
- Genes Upregulated in Prostate Cancer Reactive Stroma Promote Prostate Cancer Progression In Vivo
- (2013) O. Dakhova et al. CLINICAL CANCER RESEARCH
- Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition
- (2013) Anbarasu Kannan et al. EUROPEAN JOURNAL OF CANCER
- Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression
- (2013) Gustavo Ayala et al. JOURNAL OF PATHOLOGY
- Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
- (2012) M. A. Swartz et al. CANCER RESEARCH
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
- (2012) Yu Sun et al. NATURE MEDICINE
- Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
- (2011) Federica Sotgia et al. Annual Review of Pathology-Mechanisms of Disease
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
- (2011) Lori Rice et al. CLINICAL & EXPERIMENTAL METASTASIS
- Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate
- (2011) B Orr et al. ONCOGENE
- Stromal Caveolin-1 Expression in Breast Carcinoma. Correlation with Early Tumor Recurrence and Clinical Outcome
- (2011) Saba Mohamed El-Gendi et al. PATHOLOGY & ONCOLOGY RESEARCH
- The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer
- (2011) Ja Seung Koo et al. TUMOR BIOLOGY
- A model for phospho-caveolin-1-driven turnover of focal adhesions
- (2011) Micha Nethe et al. Cell Adhesion & Migration
- Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients
- (2010) Guillaume Ploussard et al. BJU INTERNATIONAL
- DNA Damage-Mediated Induction of a Chemoresistant Niche
- (2010) Luke A. Gilbert et al. CELL
- Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer
- (2010) Joanne Edwards EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Overexpression of Caveolin-1 in Lymphoblastoid TK6 Cells Enhances Proliferation After Irradiation with Clinically Relevant Doses
- (2010) David Barzan et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Gene expression down-regulation in CD90+prostate tumor-associated stromal cells involves potential organ-specific genes
- (2009) Laura E Pascal et al. BMC CANCER
- Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
- (2009) O. Dakhova et al. CLINICAL CANCER RESEARCH
- Radical prostatectomy for high-risk prostate cancer: Biochemical outcome
- (2009) Naoki Kawamorita et al. INTERNATIONAL JOURNAL OF UROLOGY
- The role of caveolin-1 in prostate cancer: clinical implications
- (2009) T C Thompson et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells
- (2009) Stephanie Hehlgans et al. RADIOTHERAPY AND ONCOLOGY
- Localized prostate cancer: can we better define who is at risk of unfavourable outcome?
- (2008) Steven Joniau et al. BJU INTERNATIONAL
- Caveolin-1 in tumor progression: the good, the bad and the ugly
- (2008) Jacky G. Goetz et al. CANCER AND METASTASIS REVIEWS
- Molecular Cancer Phenotype in Normal Prostate Tissue
- (2008) Thorsten Schlomm et al. EUROPEAN UROLOGY
- Caveolin-1 Up-regulation during Epithelial to Mesenchymal Transition Is Mediated by Focal Adhesion Kinase
- (2008) Kelly M. Bailey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Caveolin-1: an ambiguous partner in cell signalling and cancer
- (2008) Andrew F. G. Quest et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started